My latest “experiment” (3/09 – 4/09) has been a return from fixed pressure back to AutoPAP (ResMed S8 Vantage) and, based on the successful 11.0 cm pressure with the Activa, and with the intent of lowering the median pressure to reduce leak (though from 11.0 down to only an average of 10.7), I decided to utilize a minimum pressure of 10.0 cm. Maximum pressure was left at 20 cm, since my previous experience at that setting demonstrated no problems. Results (with previous values at 6-20 cm repeated for comparison) were as follows:
Before proceeding to an analysis of the new data, it should be pointed out that, once again, my data provides no evidence to support the "conventional wisdom" that it is preferable to set the minimum pressure just under the "titration pressure". The difference in respiratory disturbance indices when the machine is set "wide open" (6-20) or when the minimum is raised (10-20), regardless of mask, is of no clinical relevance nor of any statistical significance. In fact, the Activa efficacy parameters are slightly worse, and the UMFF parameters slightly better, than they previously were, though the differences are virtually meaningless.
Focusing on the new data at settings of 10-20 cmH2O, the Activa (without mouth taping) once again provides superior therapeutic efficacy "numbers" than does the UMFF mask, though this time the differences between the two masks are so small as to be both clinically and statistically irrelevant. Indeed, based on this data, one might accent the similarities as legitimately as the differences. This fact is particularly cogent when considering my much higher unintentional leak rate on the Activa (due to oral exhalation), as will be discussed later.
Still, it is interesting to view the efficacy parameters in a scatter plot:
Eighteen (90%) of the 20 Activa without tape nights are "within the box" (arbitrarily, AHI ≤ 10, AI ≤ 1), while only eleven (55%) of the UMFF nights are similarly situated. (Not all individual data points are visible, due to overlapping.)
While the efficacy differences between the two masks are small in this dataset, pressure-response differences between the two masks remain notable and significant. While the median pressures are almost identical (Activa = 10.7, UMFF = 11.0), the 95th centile pressures (as also noted previously at 6-20cm), are over a cm apart (Activa = 11.6, UMFF = 12.8. The difference of 1.2cm exceeds the 1.0 sum of the standard deviations.) Differences in maximum pressures are even more striking, with the Activa never exceeding 12.6 cmH2O, while the UMFF reached a maximum pressure of 16.8 cmH2O, 4.2cm higher.
While both masks display a modal pressure in the 10.0 – 10.9 cm range, the pressure profile of the Activa is narrow, at or above 12.0 only 1.7% of the time. The UMFF, however, spent notably more time at higher pressures, at or above 12.0 cm 17.1% of the time.
Similarly, apneas are seen with the Activa principally while pressure is in the 10 and 11cm ranges; only 4.7% of apneas (n = 3) were in the 12cm range, with none higher. Using the UMFF, only about half (54.6%) of the apneas occur below 12cm pressure, while the remaining apneas gradually taper off, with a single apnea appearing at the maximum pressure of 16.0 cm
Looking individually at each mask’s performance in terms of pressure distribution over time, and pressure-at-apnea distribution, we see:
For the Activa, the two plots are virtually identical.
For the UMFF, the time-pressure profile drops off more quickly than does the pressure-at-apnea profile. The significance of this observation, if any, is not clear. Still, the correspondence of curve shapes should give some pause for thought to detractors of the performance of the ResMed algorithm at pressures above 10cm.
Leak characteristics of the two masks were as follows:
These statistics are not markedly different from those previously presented. The UMFF once again displays an excellent leak profile. Due to my “lip flutter” exhalations, the Activa’s leak profile is far less desirable. Still, machine specifications are “exceeded” less than 2% of the time. In addition, none of the concerns I had previously expressed (at 11cm constant pressure) have reappeared: there have been NO individual nights with a 95th centile leak at or above 0.40 l/s (the highest has been 0.38, twice), and there have been only three nights with leak at or above 0.50 l/s (for 0.1% of total therapy time; maximum 6 minutes during any night).
A detailed examination of Activa leak status during apnea episodes, as presented previously, does not in this dataset reveal any clear pattern regarding any relationship between leaks and apnea occurrences (see subsequent note to ozij). During the (median situation) 57% of the time with NO leak reported, 64% of apneas occurred. Only a single apnea (1.6% of the total) occurred during the 1.8% of the time with “significant” leak. The number of apneas is too small to provide statistical significance.
SUMMARY In summary, the thrust of the data presented in this experiment, reinforcing the observations made earlier, is that there are significant performance differences between the Activa and the UMFF masks when used under identical conditions. While efficacy differences (i.e., AHI, AI, HI and time-in apnea) are smaller than previously reported, pressure-profile differences remain notable, though of uncertain relevance. While the presentation of my OSA may possibly include some unique characteristics, it seems likely that these differences may affect other users as well. If so, mask selection cannot be regarded as simply a "comfort" issue.
I have no information as to whether these properties are unique to these particular masks, or whether they may reflect generic performance differences between nasal and full-face masks. Still, the concept of a single physiologic "titration pressure", determinable by a single-night PSG and without reference to the interface equipment, again appears to be overly simplistic.
Finally, I expect that this will be my last posting of new data in this thread, though I anticipate that I will soon post here a "meta-analysis" overview of all the data. The choice of mask appears to be more predictive of results than the choice of machine settings. I am also beginning a project of similar data collection and analysis using the Respironics M Series AutoPAP. While we must be VERY careful "comparing" machines from different manufacturers – often the same terms are used with different meanings – preliminary indications suggest that the data will be quite interesting! I will plan to begin a new thread with that information.
For ozij, a special note We share a respect for data, a respect for statistical analysis, and a respect for each others’ honesty and integrity. I therefore must present some details, at least for you.
I again did the leak / pressure correlation analysis for the Activa mask without mouth taping, which last time supported my hypothesis. This time, the data does not support the position I had hypothesized.

There is an excess of apneas reported during low-leak conditions, with respect to the time spent in each leak category. This arguably supports your hypothesis of decreased apnea reporting during periods of higher leak.
Still, there are the same weaknesses as last time, when the data favored my view. While there are now more apnea occurrences, the data remains relatively sparse, and even small variations (and I typically engender major variations!) would skew the outcome markedly.
I remain convinced that there is no a priori reason to doubt the accuracy of apnea sensing and reporting while leak is within the machine’s specifications, whether the leak is at the mask-skin interface or whether the leak is from the mouth. As I proposed in another thread in another context, when leak is within machine specifications, pressure throughout the system, from the blower exit through the tubing and mask and within the airway is, for all practical purposes, instantaneously equilibrated, regardless of the location of the leak.
I remain unable to explain the previously presented efficacy differences between Activa with mouth taping and Activa without mouth taping. I am similarly at a loss to explain the differences I have just presented between the UMFF mask and Activa (although, as I have pointed out, efficacy similarities may be more impressive than differences!). I respect your hypothesis as a thoughtful, innovative attempt at explanation. Although I can offer no alternative explanation, I am not convinced by yours.
But I am impressed by your mind, and your suggestion cannot be idly dismissed!!
With apologies for the length of this post (obviously, I find it fascinating!), I hope that this material is of some interest, and perhaps even of some use. Blessings, Velbor